Postma MJ - Search Results

1

Clinical and economic impact of non-adherence in COPD: a systematic review.

van Boven JF, Chavannes NH, van der Molen T, Rutten-van Mölken MP, Postma MJ, Vegter S. van Boven JF, et al. Among authors: postma mj. Respir Med. 2014 Jan;108(1):103-13. doi: 10.1016/j.rmed.2013.08.044. Epub 2013 Sep 11. Respir Med. 2014. PMID: 24070566 Free article. Review.

2

Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands.

Rutten-van Mölken MP, Postma MJ, Joore MA, Van Genugten ML, Leidl R, Jager JC. Rutten-van Mölken MP, et al. Among authors: postma mj. Respir Med. 1999 Nov;93(11):779-87. doi: 10.1016/s0954-6111(99)90262-7. Respir Med. 1999. PMID: 10603626 Free article.

3

Pharmacoeconomic evaluations of pharmacogenetic and genomic screening programmes: a systematic review on content and adherence to guidelines.

Vegter S, Boersma C, Rozenbaum M, Wilffert B, Navis G, Postma MJ. Vegter S, et al. Among authors: postma mj. Pharmacoeconomics. 2008;26(7):569-87. doi: 10.2165/00019053-200826070-00005. Pharmacoeconomics. 2008. PMID: 18563949 Review.

4

Cost-effectiveness of varicella vaccination programs: an update of the literature.

Rozenbaum MH, van Hoek AJ, Vegter S, Postma MJ. Rozenbaum MH, et al. Among authors: postma mj. Expert Rev Vaccines. 2008 Aug;7(6):753-82. doi: 10.1586/14760584.7.6.753. Expert Rev Vaccines. 2008. PMID: 18665775 Free article. Review.

5

Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism.

Vegter S, Perna A, Hiddema W, Ruggenenti P, Remuzzi G, Navis G, Postma MJ. Vegter S, et al. Among authors: postma mj. Pharmacogenet Genomics. 2009 Sep;19(9):695-703. doi: 10.1097/FPC.0b013e3283307ca0. Pharmacogenet Genomics. 2009. PMID: 19696696 Free article.

6

Review of regulatory recommendations for orphan drug submissions in the Netherlands and Scotland: focus on the underlying pharmacoeconomic evaluations.

Vegter S, Rozenbaum MH, Postema R, Tolley K, Postma MJ. Vegter S, et al. Among authors: postma mj. Clin Ther. 2010 Aug;32(9):1651-61. doi: 10.1016/j.clinthera.2010.08.006. Clin Ther. 2010. PMID: 20974323

7

Health technology assessments in personalized medicine: illustrations for cost-effectiveness analysis.

Postma MJ, Boersma C, Vandijck D, Vegter S, Le HH, Annemans L. Postma MJ, et al. Expert Rev Pharmacoecon Outcomes Res. 2011 Aug;11(4):367-9. doi: 10.1586/erp.11.50. Expert Rev Pharmacoecon Outcomes Res. 2011. PMID: 21831013 No abstract available.

8

Compliance, persistence, and switching patterns for ACE inhibitors and ARBs.

Vegter S, Nguyen NH, Visser ST, de Jong-van den Berg LT, Postma MJ, Boersma C. Vegter S, et al. Among authors: postma mj. Am J Manag Care. 2011 Sep;17(9):609-16. Am J Manag Care. 2011. PMID: 21902446 Free article.

9

Cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in chronic kidney disease before and during dialysis.

Vegter S, Tolley K, Keith MS, Postma MJ. Vegter S, et al. Among authors: postma mj. Value Health. 2011 Sep-Oct;14(6):852-8. doi: 10.1016/j.jval.2011.05.005. Epub 2011 Jun 23. Value Health. 2011. PMID: 21914505 Free article.

10

Sodium intake, ACE inhibition, and progression to ESRD.

Vegter S, Perna A, Postma MJ, Navis G, Remuzzi G, Ruggenenti P. Vegter S, et al. Among authors: postma mj. J Am Soc Nephrol. 2012 Jan;23(1):165-73. doi: 10.1681/ASN.2011040430. Epub 2011 Dec 1. J Am Soc Nephrol. 2012. PMID: 22135311 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

672 results

Search Page

Filters